Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Aflibercept
Related studies linked through entity extraction aliases.
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
- Status
- COMPLETED
- Phase
- PHASE4
Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
- Status
- WITHDRAWN
- Phase
- NA
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
VITAL - Individualising Therapy for Neovascular AMD With Aflibercept
- Status
- COMPLETED
- Phase
- PHASE4
Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
- Status
- UNKNOWN
- Phase
- PHASE1
A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
- Status
- TERMINATED
- Phase
- PHASE2
Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)
- Status
- COMPLETED
- Phase
- PHASE4
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept
- Status
- COMPLETED
- Phase
- N/A
Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE4
Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients
- Status
- COMPLETED
- Phase
- PHASE2
Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD
- Status
- COMPLETED
- Phase
- N/A